Searched for: author%3A%22Scheffer%2C+P.G.%22
(1 - 3 of 3)
de Haas, M. (author), Thurik, F.F. (author), van der Ploeg, C.P.B. (author), Veldhuisen, B. (author), Hirschberg, H. (author), Soussan, A.A. (author), Woortmeijer, H. (author), Abbink, F. (author), Page-Christiaens, G.C.M.L. (author), Scheffer, P.G. (author), van der Schoot, C.E. (author)
Objective To determine the accuracy of non-invasive fetal testing for the RHD gene in week 27 of pregnancy as part of an antenatal screening programme to restrict anti-D immunoglobulin use to women carrying a child positive for RHD. Design Prospectively monitoring of fetal RHD testing accuracy compared with serological cord blood typing on...
article 2016
van der Schoot, C.E. (author), Thurik, F. (author), Scheffer, P.G. (author), Abbink, F. (author), van der Ploeg, C.P.B. (author), Veldhuisen, B. (author), de Haas, M. (author)
conference paper 2013
de Haas, M. (author), van der Ploeg, C.P.B. (author), Scheffer, P.G. (author), Verlinden, D.A. (author), Hirschberg, H. (author), Abbink, F. (author), van der Schoot, C.E. (author)
In the Netherlands, since 1 July 2011, both antenatal anti-D immunoprophylaxis (1000 IU in the 30th week of gestation) and postnatal prophylaxis (1000 IU) is administered to only those women for whom a fetal RHD typing, performed in week 27 of pregnancy, predicts the presence of a D-positive child. The fetal RHD screening is part of the...
article 2012